Maxim Group Reaffirms “Buy” Rating for Milestone Scientific Inc. (MLSS)
Milestone Scientific Inc. (NASDAQ:MLSS)‘s stock had its “buy” rating restated by analysts at Maxim Group in a research note issued to investors on Monday. They currently have a $4.00 price objective on the stock. Maxim Group’s price target indicates a potential upside of 175.86% from the company’s current price.
The analysts wrote, “Today, before the Market open, MLSS announced FDA 510(k) clearance for its CompuFlo epidural instrument (EI). The clearance was supported by the CompuFlo Assessment (COMPASS) clinical study completed in June 2016. On June 2, 2017, MLSS announced an asset purchase agreement with APAD Octrooi to purchase intellectual property (IP) for €2.2M in restricted common stock. The IP is related to the seller’s computer controlled injection instrument. On June 6, 2017, MLSS agreed to sell its 40% interest in Milestone China Ltd. to Solee Science & Technology U.S.A., Ltd.””
Shares of Milestone Scientific (MLSS) traded down 3.33% during trading on Monday, reaching $1.45. 3,235 shares of the company were exchanged. Milestone Scientific has a one year low of $1.10 and a one year high of $3.04. The company’s market capitalization is $89.12 million. The firm’s 50 day moving average price is $1.36 and its 200 day moving average price is $1.42.
ILLEGAL ACTIVITY NOTICE: “Maxim Group Reaffirms “Buy” Rating for Milestone Scientific Inc. (MLSS)” was published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/06/12/maxim-group-reaffirms-buy-rating-for-milestone-scientific-inc-mlss.html.
Milestone Scientific Company Profile
Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.
Receive News & Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.